Paeds Cases · haematology-oncology-and-transfusion
Haematopoietic stem-cell transplantation: Case
Clinical long case of a six-year-old boy with relapsed B-cell precursor acute lymphoblastic leukaemia undergoing an allogeneic haematopoietic stem-cell transplant, covering the donor selection, the conditioning, the graft-versus-host prophylaxis, the engraftment, the acute graft-versus-host disease, the sinusoidal obstruction syndrome, the febrile neutropenia, the donor chimerism and the family counselling.
On this page
Study tools
Target exams
Framing the case
This six-year-old boy is on day fourteen of an allogeneic matched unrelated donor transplant, with the weight gain, the tender hepatomegaly and the rising bilirubin that together point to the hepatic sinusoidal obstruction syndrome. The timing, within the first twenty-one days of the myeloablative conditioning, the total body irradiation and the etoposide, is the classic window for the syndrome, and the weight gain of eight percent from the baseline alongside the tender liver and the jaundice meets the diagnostic triad. The framework is the recognition that this is a hepatotoxic complication of the conditioning, distinct from the graft-versus-host disease and the drug injury, and that the early recognition and the prompt defibrotide are the decisive interventions. [8]
The differential and the diagnostic pathway
The hepatic differential at this point is the sinusoidal obstruction syndrome against the hepatic graft-versus-host disease, the drug-induced liver injury from the antifungal or the antibiotic, and the viral hepatitis. The sinusoidal obstruction syndrome presents early, within the first twenty-one days, with the weight gain and the tender liver, while the hepatic graft-versus-host presents later, often after the engraftment, with the jaundice and the gut involvement. The diagnosis of the sinusoidal obstruction syndrome is clinical, supported by the ultrasound with the doppler showing the reversal of the portal flow and the elevated hepatic pressures, with the transjugular liver biopsy and the pressure measurement in the selected case. The viral studies exclude the cytomegalovirus and the hepatitis, and the drug history excludes the reaction. [8][1]
References6ShowHide
- [1]Kanate AS, Majhail NS, Savani BN Indications for Hematopoietic Cell Transplantation and Immune Effector Cell Therapy: Guidelines from the American Society for Transplantation and Cellular Therapy Biol Blood Marrow Transplant, 2020.PMID 32165328
- [4]Bolaños-Meade J, Hamadani M, Wu J Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis N Engl J Med, 2023.PMID 37342922
- [8]Mohty M, Malard F, Alaskar AS Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a refined classification from the European Society for Blood and Marrow Transplantation Bone Marrow Transplant, 2023.PMID 37095231
- [10]Aziz MT, Kakadiya PP, Kush SM Defibrotide: An Oligonucleotide for Sinusoidal Obstruction Syndrome Ann Pharmacother, 2018.PMID 28914546
- [11]Kharfan-Dabaja MA, Kumar A, Ayala E, et al. Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation Transplant Cell Ther, 2021.PMID 34304802
- [12]Lehrnbecher T, Robinson P, Fisher B Guideline for the Management of Fever and Neutropenia in Children With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: 2017 Update J Clin Oncol, 2017.PMID 28459614